Hong Kong Hereditary Angioedema Therapeutic Market (2025-2031) | Companies, Share, Forecast, Trends, Analysis, Industry, Growth, Segmentation, Outlook, Competitive Landscape, Size & Revenue, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Hong Kong Country Macro Economic Indicators

3.2 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, 2021 & 2031F

3.3 Hong Kong Hereditary Angioedema Therapeutic Market - Industry Life Cycle

3.4 Hong Kong Hereditary Angioedema Therapeutic Market - Porter's Five Forces

3.5 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.7 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about hereditary angioedema (HAE) in Hong Kong

4.2.2 Advancements in HAE therapeutic research and development

4.2.3 Rising prevalence of HAE cases in Hong Kong

4.3 Market Restraints

4.3.1 Limited availability of approved HAE treatment options in the Hong Kong market

4.3.2 High cost associated with HAE therapies

4.3.3 Lack of specialized healthcare professionals with expertise in managing HAE in Hong Kong

6.1 Hong Kong Hereditary Angioedema Therapeutic Market, By Type

6.1.1 Overview and Analysis

6.1.2 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type I Hereditary Angioedema (HAE), 2021- 2031F

6.1.4 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type II Hereditary Angioedema (HAE), 2021- 2031F

6.1.5 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type III Hereditary Angioedema (HAE), 2021- 2031F

6.2 Hong Kong Hereditary Angioedema Therapeutic Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By C-1 Esterase Inhibitors, 2021- 2031F

6.2.3 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Bradykynin B2 Receptor Antagonist, 2021- 2031F

6.2.4 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Kallikrein Inhibitors, 2021- 2031F

6.2.5 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Others, 2021- 2031F

6.3 Hong Kong Hereditary Angioedema Therapeutic Market, By Application

6.3.1 Overview and Analysis

6.3.2 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Prophylaxis, 2021- 2031F

6.3.3 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Treatment, 2021- 2031F

6.4 Hong Kong Hereditary Angioedema Therapeutic Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Oral, 2021- 2031F

6.4.3 Hong Kong Hereditary Angioedema Therapeutic Market Revenues & Volume, By Injectable, 2021- 2031F

7.1 Hong Kong Hereditary Angioedema Therapeutic Market Export to Major Countries

7.2 Hong Kong Hereditary Angioedema Therapeutic Market Imports from Major Countries

8.1 Patient adherence rate to HAE treatment plans

8.2 Number of clinical trials conducted for HAE therapies in Hong Kong

8.3 Percentage of HAE patients receiving timely diagnosis and treatment in Hong Kong

9.1 Hong Kong Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Hong Kong Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.3 Hong Kong Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 Hong Kong Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

10.1 Hong Kong Hereditary Angioedema Therapeutic Market Revenue Share, By Companies, 2024

10.2 Hong Kong Hereditary Angioedema Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters